1887

Chapter 54 : Innate Immunity and Host Defense against Microbial Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Innate Immunity and Host Defense against Microbial Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap54-1.gif /docserver/preview/fulltext/10.1128/9781555816834/9781555814977_Chap54-2.gif

Abstract:

A principal function of the innate immune system is to perform broad-based surveillance for abnormal interactions between microbes and their hosts. Activation of innate immunity rapidly triggers a series of direct antimicrobial host defenses while simultaneously generating instructive signals, including chemokine and cytokine gene induction, that alert and mobilize a definitive adaptive immune response. Comparative genomic sequencing has revealed remarkable conservation of Toll-like receptors (TLRs) among diverse vertebrates and underlines a strong selective pressure to recognize pathogen-associated molecular patterns (PAMPs). Adaptive immunity relies on the great variability and capacity for random somatic rearrangement of gene segments to provide narrow, specific recognition of the molecular details of foreign antigens, as exemplified by antigen receptors expressed by B and T cells. Pattern recognition receptors (PRRs) are an expanding group of highly conserved molecules that detect the presence of pathogenic microbes. PRRs are transmitted to subsequent generations through the germ line and consist of various combinations of conserved modular domains that have broad specificities for structures that are unique to microbes termed PAMPs. TLRs are among the best-characterized PRRs and represent an essential first line of host immune defense. Several fungal PAMPs, including phospholipomannan and glucuronoxylomannan, activate MyD88-dependent host defense pathways, while beta-glucan, a major carbohydrate polymer of fungal cell walls, is recognized by Dectin-1, a member of the myeloid cell-expressed, NK cell receptor-like C-type lectin family. Rapid and dramatic advances in the field of innate immunity have considerable implications for the understanding of human immunodeficiency and susceptibility to infection.

Citation: Schnare M, Qureshi S. 2011. Innate Immunity and Host Defense against Microbial Infection, p 841-857. In Persing D, Tenover F, Tang Y, Nolte F, Hayden R, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555816834.ch54

Key Concept Ranking

Immune Systems
0.6315699
Immune Receptors
0.5951413
Innate Immune System
0.5654728
Adaptive Immune System
0.52920747
Major Histocompatibility Complex
0.49401346
0.6315699
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555816834.ch54
1. Adachi, K.,, H. Tsutsui,, S. Kashiwamura,, E. Seki,, H. Nakano,, O. Takeuchi,, K. Takeda,, K. Okumura,, L. Van Kaer,, H. Okamura,, S. Akira, and, K. Nakanishi. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167:59285934.
2. Akira, S.,, S. Uematsu, and, O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783801.
3. Alexopoulou, L.,, A. C. Holt,, R. Medzhitov, and, R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732738.
4. Aliprantis, A. O.,, R. B. Yang,, M. R. Mark,, S. Suggett,, B. Devaux,, J. D. Radolf,, G. R. Klimpel,, P. Godowski, and, A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736739.
5. Andersen-Nissen, E.,, K. D. Smith,, K. L. Strobe,, S. L. Barrett,, B. T. Cookson,, S. M. Logan, and, A. Aderem. 2005. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. USA 102:92479252.
6. Andrejeva, J.,, K. S. Childs,, D. F. Young,, T. S. Carlos,, N. Stock,, S. Goodbourn, and, R. E. Randall. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc. Natl. Acad. Sci. USA 101:1726417269.
7. Arnon, T. I.,, H. Achdout,, O. Levi,, G. Markel,, N. Saleh,, G. Katz,, R. Gazit,, T. Gonen-Gross,, J. Hanna,, E. Nahari,, A. Porgador,, A. Honigman,, B. Plachter,, D. Mevorach,, D. G. Wolf, and, O. Mandelboim. 2005. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6:515523.
8. Arnon, T. I.,, M. Lev,, G. Katz,, Y. Chernobrov,, A. Porgador, and, O. Mandelboim. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:26802689.
9. Arnon, T. I.,, G. Markel, and, O. Mandelboim. 2006. Tumor and viral recognition by natural killer cells receptors. Semin. Cancer Biol. 16:348358.
10. Augugliaro, R.,, S. Parolini,, R. Castriconi,, E. Marcenaro,, C. Cantoni,, M. Nanni,, L. Moretta,, A. Moretta, and, C. Bottino. 2003. Selective cross-talk among natural cytotoxicity receptors in human natural killer cells. Eur. J. Immunol. 33:12351241.
11. Banchereau, J.,, and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245252.
12. Barton, G. M.,, J. C. Kagan, and, R. Medzhitov. 2006. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7:4956.
13. Bauer, S.,, C. J. Kirschning,, H. Hacker,, V. Redecke,, S. Hausmann,, S. Akira,, H. Wagner, and, G. B. Lipford. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98:92379242.
14. Bausinger, H.,, D. Lipsker,, U. Ziylan,, S. Manie,, J. P. Briand,, J. P. Cazenave,, S. Muller,, J. F. Haeuw,, C. Ravanat,, H. de la Salle, and, D. Hanau. 2002. Endotoxinfree heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32:37083713.
15. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7:875888.
16. Bettelli, E.,, T. Korn,, M. Oukka, and, V. K. Kuchroo. 2008. Induction and effector functions of TH17 cells. Nature 453:10511057.
17. Biassoni, R.,, A. Pessino,, C. Bottino,, D. Pende,, L. Moretta, and, A. Moretta. 1999. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 29:10141020.
18. Birmingham, C. L.,, A. C. Smith,, M. A. Bakowski,, T. Yoshimori, and, J. H. Brumell. 2006. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281:1137411383.
19. Blander, J. M.,, and R. Medzhitov. 2006. On regulation of phagosome maturation and antigen presentation. Nat. Immunol. 7:10291035.
20. Blander, J. M.,, and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:10141018.
21. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907916.
22. Bottazzi, B.,, C. Garlanda,, G. Salvatori,, P. Jeannin,, A. Manfredi, and, A. Mantovani. 2006. Pentraxins as a key component of innate immunity. Curr. Opin. Immunol. 18:1015.
23. Bowie, A.,, E. Kiss-Toth,, J. A. Symons,, G. L. Smith,, S. K. Dower, and, L. A. O’Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Tolllike receptor signaling. Proc. Natl. Acad. Sci. USA 97:1016210167.
24. Brown, G. D. 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6:3343.
25. Brown, G. D.,, P. R. Taylor,, D. M. Reid,, J. A. Willment,, D. L. Williams,, L. Martinez-Pomares,, S. Y. Wong, and, S. Gordon. 2002. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 196:407412.
26. Brown, K. L.,, and R. E. Hancock. 2006. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18:2430.
27. Burns, K.,, S. Janssens,, B. Brissoni,, N. Olivos,, R. Beyaert, and, J. Tschopp. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197:263268.
28. Bustamante, J.,, S. Boisson-Dupuis,, E. Jouanguy,, C. Picard,, A. Puel,, L. Abel, and, J. L. Casanova. 2008. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr. Opin. Immunol. 20:3948.
29. Carroll, M. C.,, and M. B. Fischer. 1997. Complement and the immune response. Curr. Opin. Immunol. 9:6469.
30. Carty, M.,, R. Goodbody,, M. Schroder,, J. Stack,, P. N. Moynagh, and, A. G. Bowie. 2006. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7:10741081.
31. Casanova, J. L.,, and L. Abel. 2004. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4:5566.
32. Casanova, J. L.,, and L. Abel. 2005. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202:197201.
33. Casanova, J. L.,, and L. Abel. 2007. Primary immunodeficiencies: a field in its infancy. Science 317:617619.
34. Casrouge, A.,, S. Y. Zhang,, C. Eidenschenk,, E. Jouanguy,, A. Puel,, K. Yang,, A. Alcais,, C. Picard,, N. Mahfoufi,, N. Nicolas,, L. Lorenzo,, S. Plancoulaine,, B. Senechal,, F. Geissmann,, K. Tabeta,, K. Hoebe,, X. Du,, R. L. Miller,, B. Heron,, C. Mignot,, T. B. de Villemeur,, P. Lebon,, O. Dulac,, F. Rozenberg,, B. Beutler,, M. Tardieu,, L. Abel, and, J. L. Casanova. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308312.
35. Chamaillard, M.,, M. Hashimoto,, Y. Horie,, J. Masumoto,, S. Qiu,, L. Saab,, Y. Ogura,, A. Kawasaki,, K. Fukase,, S. Kusumoto,, M. A. Valvano,, S. J. Foster,, T. W. Mak,, G. Nunez, and, N. Inohara. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:702707.
36. Chang, Y. C.,, V. Madkan,, R. Cook-Norris,, K. Sra, and, S. Tyring. 2005. Current and potential uses of imiquimod. South. Med. J. 98:914920.
37. Checroun, C.,, T. D. Wehrly,, E. R. Fischer,, S. F. Hayes, and, J. Celli. 2006. Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc. Natl. Acad. Sci. USA 103:1457814583.
38. Choe, J.,, M. S. Kelker, and, I. A. Wilson. 2005. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309:581585.
39. Choi, K. B.,, F. Wong,, J. M. Harlan,, P. M. Chaudhary,, L. Hood, and, A. Karsan. 1998. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J. Biol. Chem. 273:2018520188.
40. Creagh, E. M.,, and L. A. O’Neill. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27:352357.
41. Creticos, P. S.,, J. T. Schroeder,, R. G. Hamilton,, S. L. Balcer-Whaley,, A. P. Khattignavong,, R. Lindblad,, H. Li,, R. Coffman,, V. Seyfert,, J. J. Eiden, and, D. Broide. 2006. Immunotherapy with a ragweed-Toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 355:14451455.
42. Crosdale, D. J.,, K. V. Poulton,, W. E. Ollier,, W. Thomson, and, D. W. Denning. 2001. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J. Infect. Dis. 184:653656.
43. Dabbagh, K.,, M. E. Dahl,, P. Stepick-Biek, and, D. B. Lewis. 2002. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J. Immunol. 168:45244530.
44. Delgado, M. A.,, R. A. Elmaoued,, A. S. Davis,, G. Kyei, and, V. Deretic. 2008. Toll-like receptors control autophagy. EMBO J. 27:11101121.
45. Deng, J. C.,, G. Cheng,, M. W. Newstead,, X. Zeng,, K. Kobayashi,, R. A. Flavell, and, T. J. Standiford. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Investig. 116:25322542.
46. Dennehy, K. M.,, and G. D. Brown. 2007. The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J. Leukoc. Biol. 82:253258.
47. Diebold, S. S.,, T. Kaisho,, H. Hemmi,, S. Akira, and, C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:15291531.
48. Dustin, L. B.,, and C. M. Rice. 2007. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 25:7199.
49. Dybdahl, B.,, A. Wahba,, E. Lien,, T. H. Flo,, A. Waage,, N. Qureshi,, O. F. Sellevold,, T. Espevik, and, A. Sundan. 2002. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through Tolllike receptor-4. Circulation 105:685690.
50. Eckert, M.,, I. Wittmann,, M. Rollinghoff,, A. Gessner, and, M. Schnare. 2006. Endotoxin-induced expression of murine bactericidal permeability/increasing protein is mediated exclusively by Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta-dependent pathways. J. Immunol. 176:522528.
51. Edelmann, K. H.,, S. Richardson-Burns,, L. Alexopoulou,, K. L. Tyler,, R. A. Flavell, and, M. B. Oldstone. 2004. Does Toll-like receptor 3 play a biological role in virus infections? Virology 322:231238.
52. Eisen, D. P.,, M. M. Dean,, M. A. Boermeester,, K. J. Fidler,, A. C. Gordon,, G. Kronborg,, J. F. Kun,, Y. L. Lau,, A. Payeras,, H. Valdimarsson,, S. J. Brett,, W. K. Ip,, J. Mila,, M. J. Peters,, S. Saevarsdottir,, J. W. van Till,, C. J. Hinds, and, E. S. McBryde. 2008. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin. Infect. Dis. 47:510516.
53. Eisenbarth, S. C.,, O. R. Colegio,, W. O’Connor,, F. S. Sutterwala, and, R. A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:11221126.
54. Eisenbarth, S. C.,, D. A. Piggott,, J. W. Huleatt,, I. Visintin,, C. A. Herrick, and, K. Bottomly. 2002. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:16451651.
55. Eriksson, U.,, R. Ricci,, L. Hunziker,, M. O. Kurrer,, G. Y. Oudit,, T. H. Watts,, I. Sonderegger,, K. Bachmaier,, M. Kopf, and, J. M. Penninger. 2003. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9:14841490.
56. Fritz, J. H.,, R. L. Ferrero,, D. J. Philpott, and, S. E. Girardin. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7:12501257.
57. Fritz, J. H.,, L. Le Bourhis,, G. Sellge,, J. G. Magalhaes,, H. Fsihi,, T. A. Kufer,, C. Collins,, J. Viala,, R. L. Ferrero,, S. E. Girardin, and, D. J. Philpott. 2007. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26:445459.
58. Gantner, B. N.,, R. M. Simmons,, S. J. Canavera,, S. Akira, and, D. M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:11071117.
59. Gantner, B. N.,, R. M. Simmons, and, D. M. Underhill. 2005. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24:12771286.
60. Gao, B.,, and M. F. Tsan. 2003. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J. Biol. Chem. 278:174179.
61. Gao, B.,, and M. F. Tsan. 2003. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J. Biol. Chem. 278:2252322529.
62. Garcia-Sastre, A.,, and C. A. Biron. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312:879882.
63. Garlanda, C.,, E. Hirsch,, S. Bozza,, A. Salustri,, M. De Acetis,, R. Nota,, A. Maccagno,, F. Riva,, B. Bottazzi,, G. Peri,, A. Doni,, L. Vago,, M. Botto,, R. De Santis,, P. Carminati,, G. Siracusa,, F. Altruda,, A. Vecchi,, L. Romani, and, A. Mantovani. 2002. Non-redundant role of the long pentraxin PTX3 in antifungal innate immune response. Nature 420:182186.
64. Gavin, A. L.,, K. Hoebe,, B. Duong,, T. Ota,, C. Martin,, B. Beutler, and, D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 314:19361938.
65. Gazit, R.,, R. Gruda,, M. Elboim,, T. I. Arnon,, G. Katz,, H. Achdout,, J. Hanna,, U. Qimron,, G. Landau,, E. Greenbaum,, Z. Zakay-Rones,, A. Porgador, and, O. Mandelboim. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7:517523.
66. Gewirtz, A. T.,, T. A. Navas,, S. Lyons,, P. J. Godowski, and, J. L. Madara. 2001. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:18821885.
67. Girardin, S. E.,, I. G. Boneca,, L. A. Carneiro,, A. Antignac,, M. Jehanno,, J. Viala,, K. Tedin,, M. K. Taha,, A. Labigne,, U. Zahringer,, A. J. Coyle,, P. S. DiStefano,, J. Bertin,, P. J. Sansonetti, and, D. J. Philpott. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:15841587.
68. Girardin, S. E.,, I. G. Boneca,, J. Viala,, M. Chamaillard,, A. Labigne,, G. Thomas,, D. J. Philpott, and, P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:88698872.
69. Girardin, S. E.,, L. H. Travassos,, M. Herve,, D. Blanot,, I. G. Boneca,, D. J. Philpott,, P. J. Sansonetti, and, D. Mengin-Lecreulx. 2003. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278:4170241708.
70. Godaly, G.,, L. Hang,, B. Frendeus, and, C. Svanborg. 2000. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J. Immunol. 165:52875294.
71. Gross, O.,, A. Gewies,, K. Finger,, M. Schafer,, T. Sparwasser,, C. Peschel,, I. Forster, and, J. Ruland. 2006. Card9 controls a non-TLR signalling pathway for innate antifungal immunity. Nature 442:651656.
72. Guillot, L.,, V. Balloy,, F. X. McCormack,, D. T. Golenbock,, M. Chignard, and, M. Si-Tahar. 2002. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:59895992.
73. Gutierrez, M. G.,, S. S. Master,, S. B. Singh,, G. A. Taylor,, M. I. Colombo, and, V. Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753766.
74. Hanna, J.,, T. Gonen-Gross,, J. Fitchett,, T. Rowe,, M. Daniels,, T. I. Arnon,, R. Gazit,, A. Joseph,, K. W. Schjetne,, A. Steinle,, A. Porgador,, D. Mevorach,, D. Goldman-Wohl,, S. Yagel,, M. J. LaBarre,, J. H. Buckner, and, O. Mandelboim. 2004. Novel APC-like properties of human NK cells directly regulate T cell activation. J. Clin. Investig. 114:16121623.
75. Happel, K. I.,, P. J. Dubin,, M. Zheng,, N. Ghilardi,, C. Lockhart,, L. J. Quinton,, A. R. Odden,, J. E. Shellito,, G. J. Bagby,, S. Nelson, and, J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761769.
76. Heil, F.,, H. Hemmi,, H. Hochrein,, F. Ampenberger,, C. Kirschning,, S. Akira,, G. Lipford,, H. Wagner, and, S. Bauer. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:15261529.
77. Hemmi, H.,, O. Takeuchi,, T. Kawai,, T. Kaisho,, S. Sato,, H. Sanjo,, M. Matsumoto,, K. Hoshino,, H. Wagner,, K. Takeda, and, S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740745.
78. Henson, P. M.,, and D. A. Hume. 2006. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27:244250.
79. Hoffman, H. M.,, J. L. Mueller,, D. H. Broide,, A. A. Wanderer, and, R. D. Kolodner. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29:301305.
80. Hoffmann, J. 2007. Antifungal defense in Drosophila. Nat. Immunol. 8:543545.
81. Hoffmann, J. A. 2003. The immune response of Drosophila. Nature 426:3338.
82. Hoffmann, J. A.,, F. C. Kafatos,, C. A. Janeway, and, R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:13131318.
83. Hohl, T. M.,, H. L. Van Epps,, A. Rivera,, L. A. Morgan,, P. L. Chen,, M. Feldmesser, and, E. G. Pamer. 2005. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 1:e30.
84. Holmskov, U.,, S. Thiel, and, J. C. Jensenius. 2003. Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21:547578.
85. Hornung, V.,, J. Ellegast,, S. Kim,, K. Brzozka,, A. Jung,, H. Kato,, H. Poeck,, S. Akira,, K. K. Conzelmann,, M. Schlee,, S. Endres, and, G. Hartmann. 2006. 5’-Triphosphate RNA is the ligand for RIG-I. Science 314:994997.
86. Hornung, V.,, S. Rothenfusser,, S. Britsch,, A. Krug,, B. Jahrsdorfer,, T. Giese,, S. Endres, and, G. Hartmann. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168:45314537.
87. Huang, W.,, L. Na,, P. L. Fidel, and, P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624631.
88. Inaba, K.,, S. Turley,, T. Iyoda,, F. Yamaide,, S. Shimoyama,, C. Reis e Sousa,, R. N. Germain,, I. Mellman, and, R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927936.
89. Inohara, N.,, Y. Ogura,, A. Fontalba,, O. Gutierrez,, F. Pons,, J. Crespo,, K. Fukase,, S. Inamura,, S. Kusumoto,, M. Hashimoto,, S. J. Foster,, A. P. Moran,, J. L. Fernandez-Luna, and, G. Nunez. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J. Biol. Chem. 278:55095512.
90. Ishibashi, Y.,, and T. Arai. 1990. Effect of gammainterferon on phagosome-lysosome fusion in Salmonella typhimurium-infected murine macrophages. FEMS Microbiol. Immunol. 2:7582.
91. Iwami, K. I.,, T. Matsuguchi,, A. Masuda,, T. Kikuchi,, T. Musikacharoen, and, Y. Yoshikai. 2000. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165:66826686.
92. Iwasaki, A.,, and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987995.
93. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54(Pt. 1):113.
94. Janeway, C. A., Jr.,, and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197216.
95. Janssens, S.,, K. Burns,, E. Vercammen,, J. Tschopp, and, R. Beyaert. 2003. MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression. FEBS Lett. 548:103107.
96. Jiang, D.,, J. Liang,, J. Fan,, S. Yu,, S. Chen,, Y. Luo,, G. D. Prestwich,, M. M. Mascarenhas,, H. G. Garg,, D. A. Quinn,, R. J. Homer,, D. R. Goldstein,, R. Bucala,, P. J. Lee,, R. Medzhitov, and, P. W. Noble. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11:11731179.
97. Jiang, Z.,, M. Zamanian-Daryoush,, H. Nie,, A. M. Silva,, B. R. Williams, and, X. Li. 2003. Poly(I-C)-induced Tolllike receptor 3 (TLR3)-mediated activation of NFκB and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 278:1671316719.
98. Jin, M. S.,, S. E. Kim,, J. Y. Heo,, M. E. Lee,, H. M. Kim,, S. G. Paik,, H. Lee, and, J. O. Lee. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:10711082.
99. Johnson, G. B.,, G. J. Brunn, and, J. L. Platt. 2004. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J. Immunol. 172:2024.
100. Johnston, J. B.,, J. W. Barrett,, S. H. Nazarian,, M. Goodwin,, D. Ricciuto,, G. Wang, and, G. McFadden. 2005. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23:587598.
101. Kanzler, H.,, F. J. Barrat,, E. M. Hessel, and, R. L. Coffman. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13:552559.
102. Kato, H.,, S. Sato,, M. Yoneyama,, M. Yamamoto,, S. Uematsu,, K. Matsui,, T. Tsujimura,, K. Takeda,, T. Fujita,, O. Takeuchi, and, S. Akira. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:1928.
103. Kato, H.,, O. Takeuchi,, S. Sato,, M. Yoneyama,, M. Yamamoto,, K. Matsui,, S. Uematsu,, A. Jung,, T. Kawai,, K. J. Ishii,, O. Yamaguchi,, K. Otsu,, T. Tsujimura,, C. S. Koh,, C. Reis e Sousa,, Y. Matsuura,, T. Fujita, and, S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101105.
104. Kaufmann, S. H. 2008. Immunology’s foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat. Immunol. 9:705712.
105. Kawai, T.,, and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131137.
106. Kawai, T.,, and S. Akira. 2007. TLR signaling. Semin. Immunol. 19:2432.
107. Kawai, T.,, K. Takahashi,, S. Sato,, C. Coban,, H. Kumar,, H. Kato,, K. J. Ishii,, O. Takeuchi, and, S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981988.
108. Kerfoot, S. M.,, E. M. Long,, M. J. Hickey,, G. Andonegui,, B. M. Lapointe,, R. C. Zanardo,, C. Bonder,, W. G. James,, S. M. Robbins, and, P. Kubes. 2004. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 173:70707077.
109. Kiechl, S.,, E. Lorenz,, M. Reindl,, C. J. Wiedermann,, F. Oberhollenzer,, E. Bonora,, J. Willeit, and, D. A. Schwartz. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347:185192.
110. Kim, H. M.,, B. S. Park,, J. I. Kim,, S. E. Kim,, J. Lee,, S. C. Oh,, P. Enkhbayar,, N. Matsushima,, H. Lee,, O. J. Yoo, and, J. O. Lee. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906917.
111. Kimbrell, D. A.,, and B. Beutler. 2001. The evolution and genetics of innate immunity. Nat. Rev. Genet. 2:256267.
112. Kobayashi, K.,, L. D. Hernandez,, J. E. Galan,, C. A. Janeway, Jr.,, R. Medzhitov, and, R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191202.
113. Kobayashi, K. S.,, M. Chamaillard,, Y. Ogura,, O. Henegariu,, N. Inohara,, G. Nunez, and, R. A. Flavell. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731734.
114. Komuro, A.,, and C. M. Horvath. 2006. RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J. Virol. 80:1233212342.
115. Krieg, A. M. 2006. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5:471484.
116. Ku, C. L.,, H. von Bernuth,, C. Picard,, S. Y. Zhang,, H. H. Chang,, K. Yang,, M. Chrabieh,, A. C. Issekutz,, C. K. Cunningham,, J. Gallin,, S. M. Holland,, C. Roifman,, S. Ehl,, J. Smart,, M. Tang,, F. J. Barrat,, O. Levy,, D. McDonald,, N. K. Day-Good,, R. Miller,, H. Takada,, T. Hara,, S. Al-Hajjar,, A. Al-Ghonaium,, D. Speert,, D. Sanlaville,, X. Li,, F. Geissmann,, E. Vivier,, L. Marodi,, B. Z. Garty,, H. Chapel,, C. Rodriguez-Gallego,, X. Bossuyt,, L. Abel,, A. Puel, and, J. L. Casanova. 2007. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204:24072422.
117. Langland, J. O.,, J. M. Cameron,, M. C. Heck,, J. K. Jancovich, and, B. L. Jacobs. 2006. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119:100110.
118. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9:495502.
119. Leadbetter, E. A.,, I. R. Rifkin,, A. M. Hohlbaum,, B. C. Beaudette,, M. J. Shlomchik, and, A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603607.
120. LeBouder, E.,, J. E. Rey-Nores,, N. K. Rushmere,, M. Grigorov,, S. D. Lawn,, M. Affolter,, G. E. Griffin,, P. Ferrara,, E. J. Schiffrin,, B. P. Morgan, and, M. O. Labeta. 2003. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171:66806689.
121. Lee, H. K.,, J. Lee, and, P. S. Tobias. 2002. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J. Immunol. 168:40124017.
122. Lee, J.,, J. H. Mo,, K. Katakura,, I. Alkalay,, A. N. Rucker,, Y. T. Liu,, H. K. Lee,, C. Shen,, G. Cojocaru,, S. Shenouda,, M. Kagnoff,, L. Eckmann,, Y. Ben-Neriah, and, E. Raz. 2006. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8:13271336.
123. Lee, M. S.,, and Y. J. Kim. 2007. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76:447480.
124. Leemans, J. C.,, G. Stokman,, N. Claessen,, K. M. Rouschop,, G. J. Teske,, C. J. Kirschning,, S. Akira,, T. van der Poll,, J. J. Weening, and, S. Florquin. 2005. Renalassociated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Investig. 115:28942903.
125. Lehrer, R. I.,, A. Barton,, K. A. Daher,, S. S. Harwig,, T. Ganz, and, M. E. Selsted. 1989. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Investig. 84:553561.
126. LeibundGut-Landmann, S.,, O. Gross,, M. J. Robinson,, F. Osorio,, E. C. Slack,, S. V. Tsoni,, E. Schweighoffer,, V. Tybulewicz,, G. D. Brown,, J. Ruland, and, C. Reis e Sousa. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630638.
127. Lemaitre, B.,, E. Nicolas,, L. Michaut,, J. M. Reichhart, and, J. A. Hoffmann. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973983.
128. Lenert, P. S. 2006. Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res. Ther. 8:203.
129. Levine, B.,, and V. Deretic. 2007. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7:767777.
130. Liew, F. Y.,, D. Xu,, E. K. Brint, and, L. A. O’Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446458.
131. Loo, Y. M.,, J. Fornek,, N. Crochet,, G. Bajwa,, O. Perwitasari,, L. Martinez-Sobrido,, S. Akira,, M. A. Gill,, A. Garcia-Sastre,, M. G. Katze, and, M. Gale, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335345.
132. Lotz, M.,, D. Gutle,, S. Walther,, S. Menard,, C. Bogdan, and, M. W. Hornef. 2006. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203:973984.
133. Lund, J. M.,, L. Alexopoulou,, A. Sato,, M. Karow,, N. C. Adams,, N. W. Gale,, A. Iwasaki, and, R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl, Acad. Sci. USA 101:55985603.
134. Maeda, S.,, L. C. Hsu,, H. Liu,, L. A. Bankston,, M. Iimura,, M. R Kagnoff,, L. Eckmann, and, M. Karin. 2005. Nod2 mutation in Crohn’s disease potentiates NF-κB activity and IL-1β processing. Science 307:734738.
135. Malani, A. N.,, and C. A. Kauffman. 2007. Changing epidemiology of rare mould infections: implications for therapy. Drugs 67:18031812.
136. Malathi, K.,, B. Dong,, M. Gale, Jr., and, R. H. Silverman. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448:816819.
137. Mancek, M.,, P. Pristovsek, and, R. Jerala. 2002. Identification of LPS-binding peptide fragment of MD-2, a Toll-receptor accessory protein. Biochem. Biophys. Res. Commun. 292:880885.
138. Mandelboim, O.,, N. Lieberman,, M. Lev,, L. Paul,, T. I. Arnon,, Y. Bushkin,, D. M. Davis,, J. L. Strominger,, J. W. Yewdell, and, A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:10551060.
139. Mariathasan, S.,, D. S. Weiss,, K. Newton,, J. McBride,, K. O’Rourke,, M. Roose-Girma,, W. P. Lee,, Y. Weinrauch,, D. M. Monack, and, V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228232.
140. Marr, K. A. 2008. Fungal infections in hematopoietic stem cell transplant recipients. Med. Mycol. 46:293302.
141. Marshak-Rothstein, A. 2006. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6:823835.
142. Martinon, F.,, K. Burns, and, J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10:417426.
143. Martinon, F.,, and J. Tschopp. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561574.
144. Martinon, F.,, and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26:447454.
145. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301305.
146. McCormack, F. X.,, and J. A. Whitsett. 2002. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Investig. 109:707712.
147. McDermott, M. F. 2002. Genetic clues to understanding periodic fevers, and possible therapies. Trends Mol. Med. 8:550554.
148. McDermott, M. F.,, and J. Tschopp. 2007. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends Mol. Med. 13:381388.
149. Medzhitov, R.,, and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298300.
150. Medzhitov, R.,, P. Preston-Hurlburt, and, C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394397.
151. Medzhitov, R.,, P. Preston-Hurlburt,, E. Kopp,, A. Stadlen,, C. Chen,, S. Ghosh, and, C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/ IL-1 receptor family signaling pathways. Mol. Cell 2:253258.
152. Meylan, E.,, K. Burns,, K. Hofmann,, V. Blancheteau,, F. Martinon,, M. Kelliher, and, J. Tschopp. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5:503507.
153. Meylan, E.,, J. Curran,, K. Hofmann,, D. Moradpour,, M. Binder,, R. Bartenschlager, and, J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:11671172.
154. Meylan, E.,, J. Tschopp, and, M. Karin. 2006. Intracellular pattern recognition receptors in the host response. Nature 442:3944.
155. Mizushima, N.,, B. Levine,, A. M. Cuervo, and, D. J. Klionsky. 2008. Autophagy fights disease through cellular self-digestion. Nature 451:10691075.
156. Morens, D. M.,, G. K. Folkers, and, A. S. Fauci. 2004. The challenge of emerging and re-emerging infectious diseases. Nature 430:242249.
157. Nagai, Y.,, S. Akashi,, M. Nagafuku,, M. Ogata,, Y. Iwakura,, S. Akira,, T. Kitamura,, A. Kosugi,, M. Kimoto, and, K. Miyake. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:667672.
158. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6:173182.
159. Ogawa, M.,, T. Yoshimori,, T. Suzuki,, H. Sagara,, N. Mizushima, and, C. Sasakawa. 2005. Escape of intracellular Shigella from autophagy. Science 307:727731.
160. Okamura, Y.,, M. Watari,, E. S. Jerud,, D. W. Young,, S. T. Ishizaka,, J. Rose,, J. C. Chow, and, J. F. Strauss III. 2001. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:1022910233.
161. O’Neill, L. A. 2006. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discov. 5:549563.
162. O’Neill, L. A.,, and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353364.
163. Osada, Y.,, M. Mitsuyama,, K. Matsumoto,, T. Une,, T. Otani,, H. Ogawa, and, K. Nomoto. 1982. Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog. Infect. Immun. 37:12851288.
164. Osada, Y.,, M. Mitsuyama,, T. Une,, K. Matsumoto,, T. Otani,, M. Satoh,, H. Ogawa, and, K. Nomoto. 1982. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections. Infect. Immun. 37:292300.
165. Ouyang, W.,, J. K. Kolls, and, Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454467.
166. Ozinsky, A.,, D. M. Underhill,, J. D. Fontenot,, A. M. Hajjar,, K. D. Smith,, C. B. Wilson,, L. Schroeder, and, A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97:1376613771.
167. Palm, N. W.,, and R. Medzhitov. 2007. Antifungal defense turns 17. Nat. Immunol. 8:549551.
168. Park, J. S.,, D. Svetkauskaite,, Q. He,, J. Y. Kim,, D. Strassheim,, A. Ishizaka, and, E. Abraham. 2004. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279:73707377.
169. Pasare, C.,, and R. Medzhitov. 2005. Control of B-cell responses by Toll-like receptors. Nature 438:364368.
170. Pasare, C.,, and R. Medzhitov. 2004. Toll-like receptors and acquired immunity. Semin. Immunol. 16:2326.
171. Pasare, C.,, and R. Medzhitov. 2003. Toll pathwaydependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:10331036.
172. Persing, D. H.,, R. N. Coler,, M. J. Lacy,, D. A. Johnson,, J. R. Baldridge,, R. M. Hershberg, and, S. G. Reed. 2002. Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol. 10:S32S37.
173. Picard, C.,, A. Puel,, M. Bonnet,, C. L. Ku,, J. Bustamante,, K. Yang,, C. Soudais,, S. Dupuis,, J. Feinberg,, C. Fieschi,, C. Elbim,, R. Hitchcock,, D. Lammas,, G. Davies,, A. Al-Ghonaium,, H. Al-Rayes,, S. Al-Jumaah,, S. Al-Hajjar,, I. Z. Al-Mohsen,, H. H. Frayha,, R. Rucker,, T. R. Hawn,, A. Aderem,, H. Tufenkeji,, S. Haraguchi,, N. K. Day,, R. A. Good,, M. A. Gougerot-Pocidalo,, A. Ozinsky, and, J. L. Casanova. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299:20762079.
174. Pichlmair, A.,, and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27:370383.
175. Pichlmair, A.,, O. Schulz,, C. P. Tan,, T. I. Naslund,, P. Liljestrom,, F. Weber, and, C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:9971001.
176. Poltorak, A.,, X. He,, I. Smirnova,, M. Y. Liu,, C. Van Huffel,, X. Du,, D. Birdwell,, E. Alejos,, M. Silva,, C. Galanos,, M. Freudenberg,, P. Ricciardi-Castagnoli,, B. Layton, and, B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:20852088.
177. Py, B. F.,, M. M. Lipinski, and, J. Yuan. 2007. Autophagy limits Listeria monocytogenes intracellular growth in the early phase of primary infection. Autophagy 3:117125.
178. Quintana-Murci, L.,, A. Alcais,, L. Abel, and, J. L. Casanova. 2007. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8:11651171.
179. Qureshi, S. T.,, L. Lariviere,, G. Leveque,, S. Clermont,, K. J. Moore,, P. Gros, and, D. Malo. 1999. Endotoxintolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615625.
180. Rakoff-Nahoum, S.,, J. Paglino,, F. Eslami-Varzaneh,, S. Edberg, and, R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229241.
181. Redecke, V.,, H. Hacker,, S. K. Datta,, A. Fermin,, P. M. Pitha,, D. H. Broide, and, E. Raz. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172:27392743.
182. Reid, S. D.,, G. Penna, and, L. Adorini. 2000. The control of T cell responses by dendritic cell subsets. Curr. Opin. Immunol. 12:114121.
183. Remer, K. A.,, M. Brcic, and, T. W. Jungi. 2003. Tolllike receptor-4 is involved in eliciting an LPS-induced oxidative burst in neutrophils. Immunol. Lett. 85:7580.
184. Roach, J. C.,, G. Glusman,, L. Rowen,, A. Kaur,, M. K. Purcell,, K. D. Smith,, L. E. Hood, and, A. Aderem. 2005. The evolution of vertebrate Toll-like receptors. Vroc. Natl. Acad. Sci. USA 102:95779582.
185. Rock, F. L.,, G. Hardiman,, J. C. Timans,, R. A. Kastelein, and, J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588593.
186. Romagne, F. 2007. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. Drug Discov. Today 12:8087.
187. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:123.
188. Romani, L.,, F. Bistoni, and, P. Puccetti. 2002. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 10:508514.
189. Rossignol, D. P.,, and M. Lynn. 2005. TLR4 antagonists for endotoxemia and beyond. Curr. Opin. Investig. Drugs 6:496502.
190. Rothenfusser, S.,, N. Goutagny,, G. DiPerna,, M. Gong,, B. G. Monks,, A. Schoenemeyer,, M. Yamamoto,, S. Akira, and, K. A. Fitzgerald. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175:52605268.
191. Roy, C. R.,, and E. S. Mocarski. 2007. Pathogen subversion of cell-intrinsic innate immunity. Nat. Immunol. 8:11791187.
192. Saijo, S.,, N. Fujikado,, T. Furuta,, S. H. Chung,, H. Kotaki,, K. Seki,, K. Sudo,, S. Akira,, Y. Adachi,, N. Ohno,, T. Kinjo,, K. Nakamura,, K. Kawakami, and, Y. Iwakura. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8:3946.
193. Saito, T.,, and M. Gale, Jr. 2007. Principles of intracellular viral recognition. Curr. Opin. Immunol. 19:1723.
194. Salzer, U.,, and B. Grimbacher. 2006. Common variable immunodeficiency: the power of co-stimulation. Semin. Immunol. 18:337346.
195. Sato, K.,, X. L. Yang,, T. Yudate,, J. S. Chung,, J. Wu,, K. Luby-Phelps,, R. P. Kimberly,, D. Underhill,, P. D. Cruz, Jr., and, K. Ariizumi. 2006. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J. Biol. Chem. 281:3885438866.
196. Schatz, D. G.,, M. A. Oettinger, and, M. S. Schlissel. 1992. V(D)J recombination: molecular biology and regulation. Annu. Rev. Immunol. 10:359383.
197. Scheel, B.,, S. Braedel,, J. Probst,, J. P. Carralot,, H. Wagner,, H. Schild,, G. Jung,, H. G. Rammensee, and, S. Pascolo. 2004. Immunostimulating capacities of stabilized RNA molecules. Eur. J. Immunol. 34:537547.
198. Schnare, M.,, G. M. Barton,, A. C. Holt,, K. Takeda,, S. Akira, and, R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947950.
199. Schnare, M.,, M. Rollinghoff, and, S. Qureshi. 2006. Toll-like receptors: sentinels of host defence against bacterial infection. Int. Arch. Allergy Immunol. 139:7585.
200. Schroder, M.,, and A. G. Bowie. 2005. TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 26:462468.
201. Schwalbe, R. A.,, B. Dahlback,, J. E. Coe, and, G. L. Nelsestuen. 1992. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 31:49074915.
202. Selsted, M. E.,, and A. J. Ouellette. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551557.
203. Seth, R. B.,, L. Sun,, C. K. Ea, and, Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669682.
204. Shevach, E. M.,, R. A. DiPaolo,, J. Andersson,, D. M. Zhao,, G. L. Stephens, and, A. M. Thornton. 2006. The lifestyle of naturally occurring CD4 + CD25 + Foxp3 + regulatory T cells. Immunol. Rev. 212:6073.
205. Shi, Y.,, J. E. Evans, and, K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516521.
206. Shimazu, R.,, S. Akashi,, H. Ogata,, Y. Nagai,, K. Fukudome,, K. Miyake, and, M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:17771782.
207. Smiley, S. T.,, J. A. King, and, W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167:28872894.
208. Smith, M. F., Jr.,, A. Mitchell,, G. Li,, S. Ding,, A. M. Fitzmaurice,, K. Ryan,, S. Crowe, and, J. B. Goldberg. 2003. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 278:3255232560.
209. Steele, C.,, L. Marrero,, S. Swain,, A. G. Harmsen,, M. Zheng,, G. D. Brown,, S. Gordon,, J. E. Shellito, and, J. K. Kolls. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J. Exp. Med. 198:16771688.
210. Steele, C.,, R. R. Rapaka,, A. Metz,, S. M. Pop,, D. L. Williams,, S. Gordon,, J. K. Kolls, and, G. D. Brown. 2005. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. l:e42.
211. Suffredini, A. F.,, R. E. Fromm,, M. M. Parker,, M. Brenner,, J. A. Kovacs,, R. A. Wesley, and, J. E. Parrillo. 1989. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321:280287.
212. Sutterwala, F. S.,, Y. Ogura,, M. Szczepanik,, M. Lara-Tejero,, G. S. Lichtenberger,, E. P. Grant,, J. Bertin,, A. J. Coyle,, J. E. Galan,, P. W. Askenase, and, R. A. Flavell. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317327.
213. Takaoka, A.,, Z. Wang,, M. K. Choi,, H. Yanai,, H. Negishi,, T. Ban,, Y. Lu,, M. Miyagishi,, T. Kodama,, K. Honda,, Y. Ohba, and, T. Taniguchi. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501505.
214. Takeda, K.,, and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16:39.
215. Taylor, P. R.,, L. Martinez-Pomares,, M. Stacey,, H. H. Lin,, G. D. Brown, and, S. Gordon. 2005. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23:901944.
216. Taylor, P. R.,, S. V. Tsoni,, J. A. Willment,, K. M. Dennehy,, M. Rosas,, H. Findon,, K. Haynes,, C. Steele,, M. Botto,, S. Gordon, and, G. D. Brown. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8:3138.
217. Termeer, C.,, F. Benedix,, J. Sleeman,, C. Fieber,, U. Voith,, T. Ahrens,, K. Miyake,, M. Freudenberg,, C. Galanos, and, J. C. Simon. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195:99111.
218. Theofilopoulos, A. N.,, R. Baccala,, B. Beutler, and, D. H. Kono. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23:307336.
219. Trinchieri, G.,, and A. Sher. 2007. Cooperation of Tolllike receptor signals in innate immune defence. Nat. Rev. Immunol. 7:179190.
220. Tsan, M. F.,, and B. Gao. 2004. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76:514519.
221. Turnbaugh, P. J.,, R. E. Ley,, M. Hamady,, C. M. Fraser-Liggett,, R. Knight, and, J. I. Gordon. 2007. The Human Microbiome Project. Nature 449:804810.
222. Uematsu, S.,, S. Sato,, M. Yamamoto,, T. Hirotani,, H. Kato,, F. Takeshita,, M. Matsuda,, C. Coban,, K. J. Ishii,, T. Kawai,, O. Takeuchi, and, S. Akira. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J. Exp. Med. 201:915923.
223. Ulev